QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In AINewsWire Editorial On AI-Driven Pharma Manufacturing
Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in an editorial published by AINewsWire, part of the Dynamic Brand Portfolio at IBN (InvestorBrandNetwork), highlighting the growing role of artificial intelligence in pharmaceutical manufacturing. The editorial underscores a sector-wide shift toward integrating AI directly into production workflows as a continuous compliance layer, enabling real-time monitoring, validation and optimization of processes to meet evolving Good Manufacturing Practice requirements, while positioning companies like Oncotelic at the intersection of biotechnology and advanced digital systems driving scalable efficiency and long-term cost advantages. To view the full press release, visit https://ibn.fm/S3jjv About Oncotelic Therapeutics Oncotelic Therapeutics, Inc. is…